Trial site

START - Los Angeles

Los Angeles, California 90025, United StatesNot linked to an institution yet

17running trials

The trials here

What the 17 trials at this site are about, from their registry records.

Conditions: Endometrial cancer5 trials
Lung cancer5 trials
Colorectal cancer4 trials
Ovarian cancer4 trials
Cervical cancer3 trials
Gastric and oesophageal cancer2 trials
Liver and biliary tract cancer2 trials
Melanoma2 trials
Metastatic breast cancer2 trials
Pancreatic cancer2 trials
Prostate cancer2 trials
Bladder cancer1 trial
and 1 more
Phase: Phase 18 trials
Phase 1/25 trials
Phase 24 trials
Status: Recruiting14 trials
Not yet recruiting3 trials
Lead sponsor: Gilead Sciences2 trials
Verastem, Inc.2 trials
Aminex Therapeutics, Inc.1 trial
Astellas Pharma Global Development, Inc.1 trial
Cogent Biosciences, Inc.1 trial
and 10 more

Running trials

Not yet recruiting
Study of TUB-040 in Participants With Unresectable or Metastatic Nonsquamous Non-small Cell Lung Cancer
NCT07806773· Phase 2· Gilead Sciences· Source
Contact: START Los Angeles
Not yet recruiting
Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy
NCT07743541· Phase 1/2· Gilead Sciences· Source
Contact: Tubulis Clinical Trial Inquiries
Recruiting
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
NCT07745361· Phase 2· Monte Rosa Therapeutics, Inc· Source
Contact: Monte Rosa Therapeutics Sponsor
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
NCT07659795· Phase 2· Verastem, Inc.· Source
Contact: START Hope Team
Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
NCT07383506· Phase 1· Cogent Biosciences, Inc.· Source
Contact: Cogent Biosciences, Inc
Recruiting
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
NCT07524322· Phase 1· Regor Pharmaceuticals Inc.· Source
Contact: Sarah Wheeler
Recruiting
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
NCT07602842· Phase 1/2· InduPro, Inc.· Source
Contact: Navid Hafez, M.D. (principal investigator)
Recruiting
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT07719361· Phase 1· Flare Therapeutics Inc.· Source
Contact: Hope Team Distribution List
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
NCT07644559· Phase 2· Verastem, Inc.· Source
Contact: Hope Team
Recruiting
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
NCT07542704· Phase 1· Kumquat Biosciences Inc.· Source
Contact: Navid Hafez
Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
NCT07488676· Phase 1/2· Astellas Pharma Global Development, Inc.· Source
Contact: Astellas Pharma Global Development, Inc
Recruiting
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
NCT07558733· Phase 1/2· Faeth Therapeutics· Source
Contact: Medical Monitor
Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
NCT07470853· Phase 1· Whitehawk Therapeutics, Inc.· Source
Contact: Linda Rodriguez
Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
NCT07287917· Phase 1/2· Aminex Therapeutics, Inc.· Source
Contact: Meribeth DePerio
Recruiting
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
NCT06880549· Phase 1· ModernaTX, Inc.· Source
Contact: Moderna WeCare Team
Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
NCT06293898· Phase 1· SystImmune Inc.· Source
Contact: Maribeth De Perio
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
NCT06004245· Phase 1· Vividion Therapeutics, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Endometrial cancer5 recruiting
Lung cancer5 recruiting
Colorectal cancer4 recruiting
Ovarian cancer4 recruiting
Cervical cancer3 recruiting
Gastric and oesophageal cancer2 recruiting
Liver and biliary tract cancer2 recruiting
Melanoma2 recruiting
Metastatic breast cancer2 recruiting
Pancreatic cancer2 recruiting
Prostate cancer2 recruiting
Bladder cancer1 recruiting
Head and neck cancer1 recruiting

Site data: ClinicalTrials.govUpdated 14 Nov 2026

Report an error